Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Pressure Monitoring, Ambulatory | 5 | 2022 | 253 | 1.930 |
Why?
|
Stroke | 26 | 2024 | 9936 | 1.370 |
Why?
|
Nigeria | 19 | 2024 | 762 | 1.310 |
Why?
|
Hypertension | 12 | 2024 | 8582 | 1.100 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2019 | 852 | 0.830 |
Why?
|
Blood Pressure | 7 | 2022 | 8520 | 0.780 |
Why?
|
Ghana | 12 | 2024 | 311 | 0.710 |
Why?
|
Health Personnel | 5 | 2024 | 3308 | 0.510 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.500 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2062 | 0.420 |
Why?
|
Africa | 7 | 2024 | 704 | 0.390 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1252 | 0.390 |
Why?
|
Circadian Rhythm | 3 | 2022 | 2567 | 0.370 |
Why?
|
Africa, Western | 6 | 2024 | 159 | 0.370 |
Why?
|
Rheumatic Heart Disease | 3 | 2016 | 167 | 0.350 |
Why?
|
Syncope | 1 | 2013 | 428 | 0.350 |
Why?
|
Echocardiography | 2 | 2019 | 4970 | 0.330 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2128 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2267 | 0.290 |
Why?
|
Medication Adherence | 1 | 2019 | 2161 | 0.280 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3854 | 0.270 |
Why?
|
Women's Health | 1 | 2015 | 2057 | 0.250 |
Why?
|
Heart Rate | 1 | 2017 | 4165 | 0.250 |
Why?
|
Prevalence | 7 | 2024 | 15639 | 0.240 |
Why?
|
Electrocardiography | 2 | 2017 | 6400 | 0.240 |
Why?
|
Case-Control Studies | 12 | 2024 | 21992 | 0.230 |
Why?
|
Risk Factors | 18 | 2024 | 74167 | 0.210 |
Why?
|
Blood Glucose | 2 | 2022 | 6366 | 0.210 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2660 | 0.200 |
Why?
|
Environmental Exposure | 1 | 2017 | 4389 | 0.200 |
Why?
|
Pneumonia, Aspiration | 1 | 2023 | 147 | 0.200 |
Why?
|
Middle Aged | 26 | 2024 | 219628 | 0.190 |
Why?
|
Adult | 27 | 2024 | 219353 | 0.190 |
Why?
|
Risk Assessment | 3 | 2021 | 24049 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2019 | 3960 | 0.170 |
Why?
|
Male | 29 | 2024 | 358602 | 0.170 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 25853 | 0.160 |
Why?
|
Qualitative Research | 3 | 2024 | 2939 | 0.160 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6643 | 0.160 |
Why?
|
Brain Ischemia | 3 | 2023 | 3128 | 0.150 |
Why?
|
Female | 28 | 2024 | 390174 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.150 |
Why?
|
Humans | 44 | 2024 | 759098 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 70 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17748 | 0.140 |
Why?
|
Disclosure | 1 | 2023 | 738 | 0.140 |
Why?
|
Systole | 1 | 2019 | 947 | 0.140 |
Why?
|
Cost of Illness | 2 | 2018 | 1937 | 0.140 |
Why?
|
Aged | 16 | 2024 | 168615 | 0.140 |
Why?
|
Tobacco Smoke Pollution | 1 | 2022 | 810 | 0.140 |
Why?
|
Prediabetic State | 1 | 2022 | 545 | 0.140 |
Why?
|
Rheumatic Fever | 1 | 2016 | 75 | 0.130 |
Why?
|
Multilingualism | 1 | 2015 | 87 | 0.120 |
Why?
|
Prognosis | 3 | 2022 | 29559 | 0.120 |
Why?
|
Phenotype | 3 | 2017 | 16524 | 0.120 |
Why?
|
Sex Factors | 3 | 2017 | 10515 | 0.110 |
Why?
|
Health Priorities | 1 | 2016 | 372 | 0.100 |
Why?
|
Endocarditis | 1 | 2016 | 351 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2018 | 813 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1826 | 0.100 |
Why?
|
Waist Circumference | 1 | 2015 | 921 | 0.100 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1999 | 0.090 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5197 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1137 | 0.080 |
Why?
|
Anticoagulants | 3 | 2020 | 4896 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2016 | 1550 | 0.080 |
Why?
|
Odds Ratio | 2 | 2022 | 9712 | 0.080 |
Why?
|
Motivation | 1 | 2019 | 1991 | 0.080 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 2363 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1719 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1203 | 0.080 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2017 | 1284 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1394 | 0.070 |
Why?
|
Age Factors | 4 | 2021 | 18391 | 0.070 |
Why?
|
MicroRNAs | 1 | 2024 | 3797 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 933 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2017 | 3201 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2253 | 0.070 |
Why?
|
Registries | 3 | 2021 | 8435 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5875 | 0.070 |
Why?
|
Fruit | 2 | 2022 | 1162 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8530 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 12793 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15262 | 0.070 |
Why?
|
Genomics | 2 | 2024 | 5778 | 0.070 |
Why?
|
Adiposity | 1 | 2015 | 1848 | 0.060 |
Why?
|
Hemorrhage | 1 | 2017 | 3606 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15726 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2023 | 80125 | 0.050 |
Why?
|
Tobacco, Smokeless | 1 | 2024 | 133 | 0.050 |
Why?
|
Heart Failure | 2 | 2018 | 11832 | 0.050 |
Why?
|
Adolescent | 6 | 2023 | 87551 | 0.050 |
Why?
|
Brain | 3 | 2023 | 26860 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 21344 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14439 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8465 | 0.040 |
Why?
|
Minerals | 1 | 2022 | 282 | 0.040 |
Why?
|
Young Adult | 4 | 2022 | 58477 | 0.040 |
Why?
|
Developing Countries | 3 | 2018 | 2862 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2022 | 58864 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15815 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1715 | 0.040 |
Why?
|
Clergy | 1 | 2018 | 79 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12871 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40083 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2021 | 926 | 0.040 |
Why?
|
Vegetables | 1 | 2022 | 1198 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20461 | 0.030 |
Why?
|
Penicillin G Benzathine | 1 | 2016 | 25 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 867 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7790 | 0.030 |
Why?
|
Program Evaluation | 1 | 2024 | 2487 | 0.030 |
Why?
|
Dexamethasone | 1 | 2023 | 1927 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1792 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 465 | 0.030 |
Why?
|
Asia | 1 | 2016 | 617 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1763 | 0.030 |
Why?
|
Diet | 2 | 2022 | 8001 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1317 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2019 | 1341 | 0.030 |
Why?
|
Cultural Characteristics | 1 | 2015 | 254 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 697 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2021 | 895 | 0.030 |
Why?
|
Focus Groups | 1 | 2018 | 1367 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36164 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2393 | 0.030 |
Why?
|
Health Education | 1 | 2018 | 1049 | 0.020 |
Why?
|
Family | 1 | 2023 | 3189 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 54190 | 0.020 |
Why?
|
Penicillins | 1 | 2014 | 400 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 15750 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20027 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1003 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7235 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2022 | 3183 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3886 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3531 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1438 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2294 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 640 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3929 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1435 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2891 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1501 | 0.020 |
Why?
|
Aspirin | 1 | 2019 | 3359 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1048 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7379 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10550 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3556 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4037 | 0.020 |
Why?
|
Caregivers | 1 | 2018 | 2213 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12580 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39213 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64867 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10732 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3694 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3617 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6165 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12896 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5366 | 0.010 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_